Literature DB >> 26044233

Use of the neutrophil to lymphocyte ratio for prediction of in-stent restenosis in bifurcation lesions.

M Balli1, H Taşolar, M Çetin, K Tekin, Ç E Çağliyan, S Türkmen, M Yilmaz, Z Elbasan, D Y Şahin, M Çayli.   

Abstract

OBJECTIVE: Percutaneous coronary interventions (PCI) are the preferred treatment for coronary artery disease, even though the development of in-stent restenosis (ISR) continues to be an important complication. Neutrophil to lymphocyte ratio (NLR) is indicative of the inflammatory process and can predict the short- and long-term prognosis of cardiovascular diseases. We investigated the relationship between ISR development and neutrophil-lymphocyte ratio (NLR) in bifurcation lesions in stable coronary artery disease (CAD) patients. PATIENTS AND METHODS: We analyzed the clinical and angiographic data of 181 consecutive stable CAD patients who had undergone successful PCI to the true bifurcation lesion from January 2010-December 2012. Patients were divided into two groups based on the development of ISR (group 1, ISR -; group 2, ISR +).
RESULTS: NLR(after) (p < 0.001) and NLRΔ (p < 0.001) were significantly higher in group 2. NLRΔ was found to be significant independent predictor of ISR in the multivariate logistic regression analysis. A NLRΔ level > 0.58 mg/dL had 81.8% sensitivity and 93.5% specificity for the prediction of ISR, as identified by the ROC curve. A NLR(after) level > 3.43 predicted ISR with 45.5% sensitivity and 95.8% specificity. The comparison of ROC curve analysis demonstrated that NLRΔ was the strongest independent predictor of ISR (p = 0.001).
CONCLUSIONS: As a result, although drug eluting stent implantation is known to be recommended in the bifurcation lesion PCI in worldwide, we want to emphasize the usage of the NLR values in the prediction of ISR. So, we think that NLRΔ levels may be a useful marker for the prediction of ISR in patients who undergo bifurcation PCI.

Entities:  

Mesh:

Year:  2015        PMID: 26044233

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  3 in total

1.  Blood level of CD45+ platelets and development of restenosis after drug-eluting stent implantation in patients with stable coronary artery disease.

Authors:  Zufar Gabbasov; Sergey Kozlov; Svetlana Byazrova; Olga Saburova; Ivan Melnikov; Martin Caprnda; Eduard Curilla; Ludovit Gaspar; Peter Kruzliak; Vladimir Smirnov
Journal:  Wien Klin Wochenschr       Date:  2016-09-08       Impact factor: 1.704

2.  The relationship between neutrophil-lymphocyte ratio and in-stent restenosis in superficial femoral artery.

Authors:  Yaobo Yang; Fangfang Ge; Jing Shen; Jianbo Song; Jiapei Xie; Jiangshuai Qu; Xinzu Mao; Zhaocheng Kuang; Xiang Wang; Yejun Wu; Shenghai Wang; Liang Xiao
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

Review 3.  The role of inflammation in cardiovascular diseases: the predictive value of neutrophil-lymphocyte ratio as a marker in peripheral arterial disease.

Authors:  Feliciano Chanana Paquissi
Journal:  Ther Clin Risk Manag       Date:  2016-05-27       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.